No connection between the level of exposition to statins in the population and the incidence/mortality of acute myocardial infarction: An ecological study based on Sweden's municipalities

Table 2 Utilisation of statins, acute myocardial infarction (AMI)-mortality, AMI-incidence and coronary revascularisation rates in Sweden's 289 municipalities' female populations, 1998-2002.

	Utilisation of statins DDD/TID¹
Age/years	1998	1999	2000	2001	2002
40-49	4.98 (0.27-18.7)	6.68 (0.2-32.7)	9.22 (0.13-41.3)	11.2 (0.82-46.4)	13.1 (0.88-38.2)
50-59	19.6 (2.14-59.9)	28.2 (6.45-86.8)	40.3 (11.0-135)	50.6 (15.6-207)	61.5 (20.8-221)
60-69	49.8 (7.52-120)	69.8 (10.7-162)	96.2 (18.1-206)	119 (40.7-251)	141 (45.3-288)
70-79	45.7 (3.05-128)	67.1 (17.4-178)	97.8 (30.9-250)	131 (40.3-315)	165 (56.2-354)
	AMI-Mortality/1000 ¹
Age/years	1998	1999	2000	2001	2002
40-49	0.06 (0-2.56)	0.06 (0-2.36)	0.07 (0-2.60)	0.05 (0-2.56)	0.04 (0-3.36)
50-59	0.15 (0-2.02)	0.17 (0-4.59)	0.22 (0-2.69)	0.21 (0-4.07)	0.19 (0-3.02)
60-69	0.86 (0-8.06)	1.00 (0-7.16)	0.91 (0-7.16)	0.87 (0-7.17	0.75 (0-8.33)
70-79	3.96 (0-15.3)	3.92 (0-17.2)	3.46 (0-13.9)	2.98 (0-13.7)	3.00 (0-20.0)
	AMI-Incidence/1000 ¹
Age/years	1998	1999	2000	2001	2002
40-49	0.45 (0-4.75)	0.46 (0-4.14)	0.41 (0-4.72)	0.46 (0-7.47)	0.42 (0-5.35)
50-59	1.28 (0-10.9)	1.48 (0-5.74)	1.46 (0-8.45)	1.57 (0-11.1)	1.53 (0-6.37)
60-69	4.28 (0-15.4)	4.36 (0-18.0)	4.19 (0-15.7)	4.51 (0-31.7)	4.49 (0-14.9)
70-79	13.1 (0-33.5)	12.8 (0-33.4)	12.6 (0-47.4)	13.0 (0-31.2)	12.8 (0-35.2)
	Coronary-Revascularisation/1000 ¹
Age/years	1998	1999	2000	2001	2002
40-49	0.32 (0-3.36)	0.28 (0-4.14)	0.32 (0-2.14)	0.34 (0-3.30)	0.42 (0-5.35)
50-59	0.95 (0-5.88)	1.13 (0-6.56)	1.24 (0-8.45)	1.28 (0-7.85)	1.25 (0-8.06)
60-69	2.49 (0-11.9)	2.42 (0-15.7)	2.66 (0-12.2)	3.08 (0-13.6)	3.18 (0-11.3)
70-79	3.28 (0-17.2)	3.24 (0-13.1)	3.87 (0-19.1)	3.95 (0-31.9)	4.60 (0-17.4)

Utilisation of statins expressed as Defined Daily Doses per 1000 Inhabitants and Day (DDD/TID).
¹ Mean (range)

ISSN: 1477-5751